A better understanding of mechanisms involved in regulation of drug sensitivity is crucial for improved cancer treatment. New studies show that cells of the tumor microenvironment modulate the response of cancer cells to chemotherapy and targeted therapies through production of secreted factors (pages 1359–1368).
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
CDK5RAP3 acts as a tumour suppressor in gastric cancer through the infiltration and polarization of tumour-associated macrophages
Cancer Gene Therapy Open Access 23 August 2022
-
3D micro-organisation printing of mammalian cells to generate biological tissues
Scientific Reports Open Access 10 November 2020
-
Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells
Cell Death Discovery Open Access 02 June 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Flaherty, K.T. et al. N. Engl. J. Med. 363, 809–819 (2010).
Slamon, D.J. et al. N. Engl. J. Med. 344, 783–792 (2001).
Maemondo, M. et al. N. Engl. J. Med. 362, 2380–2388 (2010).
Amado, R.G. et al. J. Clin. Oncol. 26, 1626–1634 (2008).
Hanahan, D. & Coussens, L.M. Cancer Cell 21, 309–322 (2012).
Pietras, K. & Ostman, A. Exp. Cell Res. 316, 1324–1331 (2010).
Sun, Y. et al. Nat. Med. 18, 1359–1368 (2012).
Straussman, R. et al. Nature 487, 500–504 (2012).
Wilson, T.R. et al. Nature 487, 505–509 (2012).
Acharyya, S. et al. Cell 150, 165–178 (2012).
Nakasone, E.S. et al. Cancer Cell 21, 488–503 (2012).
McMillin, D.W. et al. Nat. Med. 16, 483–489 (2010).
Martinez-Outschoorn, U.E. et al. Cancer Biol. Ther. 12, 924–938 (2011).
Pontiggia, O. et al. Breast Cancer Res. Treat. 133, 459–471 (2012).
Shekhar, M.P., Santner, S., Carolin, K.A. & Tait, L. Am. J. Pathol. 170, 1546–1560 (2007).
Johansson, A.C. et al. Mol. Cancer Res. 10.1158/1541-7786.MCR-12-0030 (18 July 2012).
Wang, W. et al. Clin. Cancer Res. 15, 6630–6638 (2009).
Lindström, L.S. et al. J. Clin. Oncol. 30, 2601–2608 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Östman, A. The tumor microenvironment controls drug sensitivity. Nat Med 18, 1332–1334 (2012). https://doi.org/10.1038/nm.2938
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2938
This article is cited by
-
Mesenchymal stromal cells confer breast cancer doxorubicin resistance by producing hyaluronan
Oncogene (2023)
-
CDK5RAP3 acts as a tumour suppressor in gastric cancer through the infiltration and polarization of tumour-associated macrophages
Cancer Gene Therapy (2023)
-
Stromal nicotinamide N-methyltransferase orchestrates the crosstalk between fibroblasts and tumour cells in oral squamous cell carcinoma: evidence from patient-derived assembled organoids
Oncogene (2023)
-
3D micro-organisation printing of mammalian cells to generate biological tissues
Scientific Reports (2020)
-
MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p/AMPK/PGC1α/CEBPB axis to promote stemness and chemo-resistance of gastric cancer
Cell Death & Disease (2020)
